Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivoJi Young Yoo, Balveen Kaur, Tae Jin Lee et al.|Neuro-Oncology|2019Cited by 50
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Mitra Nair et al.|Molecular Cancer Therapeutics|2019Cited by 33
Supplementary Figure S4 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Mitra Nair et al.|Unknown|2023Cited by 0
Supplementary Figure S3 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Yeshavanth Banasavadi‐Siddegowda et al.|Unknown|2023Cited by 0
Supplementary Figure S2 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Mitra Nair et al.|Unknown|2023Cited by 0